TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21187305

Group type: EXPERIMENTAL
Intervention: Automated Fio(2) adjustment
Number of subjects: 32
Study: 17531251

Group type: EXPERIMENTAL
Intervention: Bepridil
Number of subjects: 29
Study: 15011106

Group type: EXPERIMENTAL
Intervention: Individualized psychotherapeutic support during hospital stay
Number of subjects: 106

Group type: COMPARATOR
Intervention: Classical music program
Number of subjects: 106
Study: 11442551

Group type: EXPERIMENTAL
Intervention: 100 mg of aspirin every other day (n = 525)
Number of subjects: 1001

Group type: COMPARATOR
Intervention: Aspirin placebo (n = 476)
Number of subjects: 1001
Study: 10357955

Group type: EXPERIMENTAL
Intervention: Prednisolone 10 mg at night
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7498099

Group type: EXPERIMENTAL
Intervention: Olestra (24 g) with moderate fibre (7 g/meal)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Olestra (24 g) with high fibre (24 g/meal)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo with moderate fibre (7 g/meal)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo with high fibre (24 g/meal)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Olestra (24 g)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 1955634

Group type: EXPERIMENTAL
Intervention: Phazer
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pricker
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Modified prick tests
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Stallerkit
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Morrow Brown
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Allerkit
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Stallerpointe
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Wyeth Needle
Number of subjects: 8
Study: 6958195

Group type: EXPERIMENTAL
Intervention: Hypnosis during mental stress recall
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mental stress (mental arithmetic)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (unstressed subjects)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mental stress
Number of subjects: 0
Study: 30951167

Group type: EXPERIMENTAL
Intervention: 10 mg per-oral morphine
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 50 mg per-oral naltrexone
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 29911741

Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss only (D)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss plus exercise (D + E)
Number of subjects: 240
Study: 27253693

Group type: EXPERIMENTAL
Intervention: Carbon-finance approved cookstove intervention
Number of subjects: 187

Group type: COMPARATOR
Intervention: Traditional stoves (control)
Number of subjects: 187
Study: 24296163

Group type: EXPERIMENTAL
Intervention: Flowable resin composite (Tetric Evo Flow)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional resin-based sealant (Helioseal F)
Number of subjects: 34
Study: 22855916

Group type: EXPERIMENTAL
Intervention: Porridge made with pinhead oats (P)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Porridge made with rolled oats (R)
Number of subjects: 13
Study: 20696421

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment program
Number of subjects: 45

Group type: COMPARATOR
Intervention: Waitlist-control condition
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment program (after waitlist)
Number of subjects: 45
Study: 18281409

Group type: EXPERIMENTAL
Intervention: Atomoxetine (0.8-1.8 mg/kg per day)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Osmotically released methylphenidate (18-54 mg/day)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Atomoxetine after methylphenidate
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Osmotically released methylphenidate after atomoxetine
Number of subjects: 222
Study: 15689584

Group type: EXPERIMENTAL
Intervention: Bilateral pallidal stimulation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Neurostimulation
Number of subjects: 22
Study: 12603516

Group type: EXPERIMENTAL
Intervention: Behavioural sleep intervention (4-week duration)
Number of subjects: 155
Study: 10229280

Group type: EXPERIMENTAL
Intervention: Adhesive ankle taping
Number of subjects: 12

Group type: COMPARATOR
Intervention: No tape (control)
Number of subjects: 12
Study: 8634927

Group type: EXPERIMENTAL
Intervention: Interlocking nails
Number of subjects: 107

Group type: COMPARATOR
Intervention: Ender nails
Number of subjects: 107
Study: 1473428

Group type: EXPERIMENTAL
Intervention: Low-dose Al antacid (1 tablet four times a day)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cimetidine (800 mg at bedtime)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 6426646

Group type: EXPERIMENTAL
Intervention: 14 valent pneumococcal vaccine
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Penicillin
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 242
Study: 30615000

Group type: EXPERIMENTAL
Intervention: Classic septoplasty (n: 25)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Extracorporeal septoplasty (n: 14)
Number of subjects: 39
Study: 29139301

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 or 25 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27511856

Group type: EXPERIMENTAL
Intervention: (18)F‐Fluciclovine PET-CT
Number of subjects: 41
Study: 22289010

Group type: EXPERIMENTAL
Intervention: Standard course with role play
Number of subjects: 48

Group type: COMPARATOR
Intervention: Alternative course with no role play
Number of subjects: 48
Study: 20453546

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid/carboxymethylcellulose (HA/CMC) dressing
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control (unpacked side)
Number of subjects: 53
Study: 18395910

Group type: EXPERIMENTAL
Intervention: Endoscopic hemoclip placement (EHP)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Endoscopic band ligation (EBL)
Number of subjects: 41
Study: 16521845

Group type: COMPARATOR
Intervention: CHO (9.3% carbohydrate solution)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: CHO-PRO (9.3% carbohydrate solution plus 1.5% protein)
Number of subjects: 16
Study: 12180579

Group type: EXPERIMENTAL
Intervention: Erythromycin 200 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nizatidine 300 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 60
Study: 10494641

Group type: EXPERIMENTAL
Intervention: Supplementary oxygen (2 L/min)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 40
Study: 8740798

Group type: EXPERIMENTAL
Intervention: Paclitaxel at dose levels of 135, 170, 200, 250, and 300 mg/m2 (24-hour infusion); 250 mg/m2 (one-hour infusion)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Ifosfamide at a dose of 1.6 g/m2 i.v. bolus daily for 3 days with mesna uroprotection
Number of subjects: 31
Study: 8391065

Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy (seven further cycles of CDE: cyclophosphamide 1 g/m2, doxorubicin 45 mg/m2, etoposide 100 mg/m2)
Number of subjects: 687

Group type: COMPARATOR
Intervention: Follow-up (no further chemotherapy)
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy (seven further cycles of CDE)
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: Both arms (maintenance and follow-up)
Number of subjects: 687
Study: 3551088

Group type: EXPERIMENTAL
Intervention: Experimental cardiac rehabilitation program (rehab care)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Conventional hospital rehabilitation (usual care)
Number of subjects: 180
Study: 29301555

Group type: EXPERIMENTAL
Intervention: OPTimal nutrition by Informing and Capacitating FMs of best practices (OPTICs)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: ICU Workbook (web-based decision-support intervention)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150
Study: 27209611

Group type: EXPERIMENTAL
Intervention: Saphenous vein (SV) composite grafts
Number of subjects: 363

Group type: COMPARATOR
Intervention: Total arterial (TA) composite grafts
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Saphenous vein (SV) composite grafts (propensity score-matched)
Number of subjects: 363

Group type: COMPARATOR
Intervention: Total arterial (TA) composite grafts (propensity score-matched)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Overall survival (both groups)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Freedom from major adverse cardiac and cerebrovascular events (both groups)
Number of subjects: 363
Study: 26232137

Group type: EXPERIMENTAL
Intervention: 12 oz. 100% berry fruit juice
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 12 oz. water
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 100% fruit juice
Number of subjects: 26
Study: 22658845

Group type: EXPERIMENTAL
Intervention: Contoured orthosis
Number of subjects: 12

Group type: COMPARATOR
Intervention: Flat insert
Number of subjects: 12
Study: 21795458

Group type: EXPERIMENTAL
Intervention: 1 dose of the 2009 monovalent pandemic influenza A/H1N1 MF59-adjuvanted vaccine (PV) coadministered with 1 dose of the seasonal 2009-2010 trivalent nonadjuvanted influenza vaccine (SV)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 2 doses of the 2009 monovalent pandemic influenza A/H1N1 MF59-adjuvanted vaccine (PV) coadministered with 1 dose of the seasonal 2009-2010 trivalent nonadjuvanted influenza vaccine (SV)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 1 dose of the seasonal 2009-2010 trivalent nonadjuvanted influenza vaccine (SV)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 1 dose of the 2009 monovalent pandemic influenza A/H1N1 MF59-adjuvanted vaccine (PV) and 2 doses of PV
Number of subjects: 66
Study: 19464414

Group type: EXPERIMENTAL
Intervention: Istaroxime
Number of subjects: 120
Study: 16945877

Group type: EXPERIMENTAL
Intervention: Pain assessment scales (intervention group)
Number of subjects: 772

Group type: COMPARATOR
Intervention: Usual practice (control group)
Number of subjects: 772
Study: 15265241

Group type: EXPERIMENTAL
Intervention: telithromycin 800 mg once daily for 5, 7, or 10 days
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: telithromycin 800 mg once daily for 7-10 days
Number of subjects: 1023

Group type: COMPARATOR
Intervention: clarithromycin 500 mg twice daily for 10 days
Number of subjects: 1023
Study: 11764434

Group type: EXPERIMENTAL
Intervention: Futura-type wrist splint
Number of subjects: 201

Group type: COMPARATOR
Intervention: Traditional forearm plaster-of-Paris cast
Number of subjects: 201
Study: 10090696

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8033435

Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin (IVIG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control treatments (anti-cholinesterase drugs, thymectomy, corticosteroids, immunosuppressants, plasma exchange)
Number of subjects: 0
Study: 2645845

Group type: EXPERIMENTAL
Intervention: Nutritional intervention in place of antihypertensive drugs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drug therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Holter monitoring, echocardiography, roentgenography, and electrocardiography
Number of subjects: 0
Study: 28397962

Group type: EXPERIMENTAL
Intervention: General explanations in biology
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: General explanations in physics
Number of subjects: 149
Study: 27538003

Group type: EXPERIMENTAL
Intervention: CaHA (+) with integral 0.3% lidocaine
Number of subjects: 102

Group type: COMPARATOR
Intervention: CaHA without lidocaine
Number of subjects: 102
Study: 24640268

Group type: EXPERIMENTAL
Intervention: 100 ml dexamethasone/bupivacaine/gentamicin (DMG) solution
Number of subjects: 20

Group type: COMPARATOR
Intervention: 100 ml saline solution
Number of subjects: 20
Study: 21873895

Group type: EXPERIMENTAL
Intervention: Follow-on formula supplemented with Lactobacillus fermentum CECT5716 plus galactooligosaccharide (EG)
Number of subjects: 100
Study: 20690094

Group type: EXPERIMENTAL
Intervention: Early and intensive statin therapy (60 mg immediately and 40 mg/day atorvastatin)
Number of subjects: 586

Group type: COMPARATOR
Intervention: Conventional statin therapy (10 mg/day atorvastatin)
Number of subjects: 586
Study: 18646702

Group type: EXPERIMENTAL
Intervention: XELOX (Capecitabine plus Oxaliplatin)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: mFOLFOX4
Number of subjects: 256

Group type: COMPARATOR
Intervention: de Gramont regimen
Number of subjects: 256
Study: 16167963

Group type: EXPERIMENTAL
Intervention: Oxytocin (50 IU)
Number of subjects: 572

Group type: COMPARATOR
Intervention: Placebo (sterile water in 25 mL saline)
Number of subjects: 572
Study: 12876178

Group type: EXPERIMENTAL
Intervention: Synthetic human secretin 2 U/kg
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 62
Study: 10561323

Group type: EXPERIMENTAL
Intervention: PCR with tyrosinase
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: PCR with MART‐1
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: MART‐1-positive CMCs
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Tyrosinase-positive CMCs
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Tyrosinase and MART‐1 expression
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Tyrosinase-positive but MART‐1-negative CMCs
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: MART‐1 and tyrosinase PCR
Number of subjects: 186
Study: 2091361

Group type: EXPERIMENTAL
Intervention: Citrate-containing glucose electrolyte solution (GES)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Maize-salt solution (MSS)
Number of subjects: 115
Study: 381074

Group type: EXPERIMENTAL
Intervention: Commercialized anatoxin (30 Lf per dose, adsorbed on Ca phosphate)
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: Commercialized anatoxin (30 Lf per dose, adsorbed on Al hydroxide)
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: Experimental anatoxin (25 Lf per dose, adsorbed on Al phosphate)
Number of subjects: 595

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 595
Study: 31035187

Group type: EXPERIMENTAL
Intervention: Physostigmine salicylate (0.04 mg/kg initial dose, followed by continuous infusion of 1 mg/h for 120 h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Physostigmine salicylate
Number of subjects: 20
Study: 28450262

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy using diode laser 660 nm mediated by methylene blue (MB)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Topical corticosteroids (kenakort A-orabase)
Number of subjects: 20
Study: 26374203

Group type: EXPERIMENTAL
Intervention: 3 month Tobacco Status Project intervention on Facebook
Number of subjects: 0

Group type: COMPARATOR
Intervention: Referral to a smoking cessation website
Number of subjects: 0
Study: 24293994

Group type: EXPERIMENTAL
Intervention: NPPV (bilevel positive airway pressure, 15/5 cm H2O)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual therapy (Control)
Number of subjects: 30
Study: 21133980

Group type: EXPERIMENTAL
Intervention: rhPDGF‐BB+β‐TCP
Number of subjects: 54

Group type: COMPARATOR
Intervention: β‐TCP
Number of subjects: 54
Study: 19958541

Group type: EXPERIMENTAL
Intervention: Verum acupuncture (treatment group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham acupuncture (control group)
Number of subjects: 0
Study: 17310937

Group type: EXPERIMENTAL
Intervention: Personalized cognitive counseling (PCC)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Usual counseling (UC)
Number of subjects: 336
Study: 15026904

Group type: EXPERIMENTAL
Intervention: One proximal endoloop (group 1)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Two proximal endoloops (group 2)
Number of subjects: 208
Study: 11777865

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 1 g intravenous single dose followed by oral cefixime
Number of subjects: 144

Group type: COMPARATOR
Intervention: Daily intravenous dose of 1 g ceftriaxone
Number of subjects: 144
Study: 9693354

Group type: EXPERIMENTAL
Intervention: Combined hormonal replacement therapy
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Sequential hormonal replacement therapy
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 8081181

Group type: EXPERIMENTAL
Intervention: 40% nitrous oxide
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 60% nitrous oxide
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 80% nitrous oxide
Number of subjects: 12

Group type: COMPARATOR
Intervention: 0% (oxygen-placebo)
Number of subjects: 12
Study: 2723991

Group type: EXPERIMENTAL
Intervention: Pediatric surgical service (P-Surg)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Adult surgical services (G-Surg)
Number of subjects: 139
Study: 394303

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Dixyrazine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 31416489

Group type: EXPERIMENTAL
Intervention: iCBT (translated Wellbeing Course)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 63
Study: 31007103

Group type: EXPERIMENTAL
Intervention: Percutaneous curved vertebroplasty (PCVP)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Unilateral percutaneous vertebroplasty (PVP)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Bilateral percutaneous vertebroplasty (PVP)
Number of subjects: 78
Study: 28583145

Group type: EXPERIMENTAL
Intervention: De Qi group (enhanced stimulation to evoke De Qi)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (weak stimulation to avoid De Qi)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: De Qi group
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 88
Study: 26453554

Group type: EXPERIMENTAL
Intervention: Training plus clinical reminder system (TC)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Training plus clinical reminder system plus referral to a village health worker (TCR)
Number of subjects: 26
Study: 24120756

Group type: EXPERIMENTAL
Intervention: Multimedia visual perceptual group training
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Multimedia visual perceptual individual training
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Paper visual perceptual group training
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 64
Study: 23010962

Group type: EXPERIMENTAL
Intervention: Weight at 1 year
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: αCa (calcium absorption)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Birth weight
Number of subjects: 123
Study: 19858706

Group type: EXPERIMENTAL
Intervention: Cholecystectomy
Number of subjects: 302

Group type: COMPARATOR
Intervention: Hernia repair
Number of subjects: 302
Study: 18241560

Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic surgery (HALS)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Open surgery (OS)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both HALS and OS
Number of subjects: 42
Study: 16162254

Group type: EXPERIMENTAL
Intervention: Fixed combination of 250 mg acetylsalicylic acid + 200 mg paracetamol + 50 mg caffeine (Thomapyrin)
Number of subjects: 1743

Group type: COMPARATOR
Intervention: All active treatments except caffeine
Number of subjects: 1743
Study: 12355200

Group type: EXPERIMENTAL
Intervention: 6% CHS
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 12% CHS
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 10439763

Group type: EXPERIMENTAL
Intervention: Ketamine 0.15 mg/kg as a 5‐mL i.v. injection 5 min before surgery
Number of subjects: 128

Group type: COMPARATOR
Intervention: Isotonic saline 5 mL i.v. at the time of skin closure
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Ketamine 0.15 mg/kg i.v. at the time of skin closure
Number of subjects: 128
Study: 8574255

Group type: EXPERIMENTAL
Intervention: Mifepristone 600 mg + Misoprostol 400 micrograms (1st dose) + Misoprostol 200 micrograms (2nd dose if needed)
Number of subjects: 1108

Group type: EXPERIMENTAL
Intervention: Mifepristone 600 mg + Misoprostol 400 micrograms (1st dose) + Misoprostol 600 micrograms (2nd dose)
Number of subjects: 1108

Group type: COMPARATOR
Intervention: Mifepristone 600 mg + Misoprostol 400 micrograms (1st dose)
Number of subjects: 1108

Group type: EXPERIMENTAL
Intervention: Mifepristone 600 mg + Misoprostol 400 micrograms (1st dose) + Misoprostol 200 micrograms (2nd dose)
Number of subjects: 1108

Group type: EXPERIMENTAL
Intervention: Mifepristone and Misoprostol
Number of subjects: 1108
Study: 2229278

Group type: EXPERIMENTAL
Intervention: Octreotide (50 micrograms sc every 8 h, increased to 200 micrograms)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 20
Study: 7446925

Group type: EXPERIMENTAL
Intervention: Spinal intradural analgesia
Number of subjects: 150

Group type: COMPARATOR
Intervention: General anaesthesia with spontaneous ventilation (Group B)
Number of subjects: 150

Group type: COMPARATOR
Intervention: General anaesthesia with controlled ventilation (Group C)
Number of subjects: 150
Study: 31926846

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD)
Number of subjects: 3
Study: 30559055

Group type: EXPERIMENTAL
Intervention: Amniotic membrane seeded with fetal fibroblasts (AM-F group)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Amniotic membrane (AM group)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Vaseline gauze (control group)
Number of subjects: 10
Study: 28963455

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 118

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 118
Study: 25463456

Group type: EXPERIMENTAL
Intervention: Memorization of a complex artificial pattern followed by mental rotation of the image as instructed by a cue.
Number of subjects: 0
Study: 23732073

Group type: EXPERIMENTAL
Intervention: Tensor tenotomy with tensor tenopexy (n=9)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Tensor tenotomy (n=8)
Number of subjects: 17